Merkel cell carcinoma, stage I

Clinical trials for Merkel cell carcinoma, stage I explained in plain language.

Never miss a new study

Get alerted when new Merkel cell carcinoma, stage I trials appear

Sign up with your email to follow new studies for Merkel cell carcinoma, stage I, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet finished but already full! 1

Immunotherapy drug aims to stop rare skin cancer's return

Disease control Ongoing

This study tests whether the immunotherapy drug avelumab can help prevent Merkel cell carcinoma, a rare skin cancer, from returning after initial treatment. About 122 adults with stage I to III Merkel cell carcinoma will receive either avelumab or a placebo. The main goal is to s…

Matched conditions: MERKEL CELL CARCINOMA, STAGE I

Phase 2 • Sponsor: Melanoma and Skin Cancer Trials Limited • Aim: Disease control

Last updated Jun 27, 2026 12:05 UTC

Merkel cell carcinoma, stage I

Get alerted when new Merkel cell carcinoma, stage I trials appear

Immunotherapy drug aims to stop rare skin cancer's return